| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EFX | Common Stock | Sale | $27,339 | -91 | -0.6% | $300.43 | 15,168 | 28 Aug 2024 | Direct | F1, F2, F3 |
| transaction | EFX | Common Stock | Sale | $91,291 | -300 | -2% | $304.30 | 14,868 | 28 Aug 2024 | Direct | F1, F3, F4 |
| transaction | EFX | Common Stock | Sale | $148,625 | -484 | -3.3% | $307.08 | 14,384 | 28 Aug 2024 | Direct | F1, F3, F5 |
| transaction | EFX | Common Stock | Sale | $179,630 | -593 | -4.1% | $302.92 | 13,791 | 28 Aug 2024 | Direct | F1, F3, F6 |
| transaction | EFX | Common Stock | Sale | $222,448 | -729 | -5.3% | $305.14 | 13,062 | 28 Aug 2024 | Direct | F1, F3, F7 |
| transaction | EFX | Common Stock | Sale | $245,645 | -803 | -6.1% | $305.91 | 12,259 | 28 Aug 2024 | Direct | F1, F3, F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. |
| F2 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $300.39 to $300.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F3 | Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| F4 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $303.735 to $304.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F5 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $306.73 to $307.405, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F6 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $302.61 to $303.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F7 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $304.73 to $305.70, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F8 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $305.73 to $306.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |